These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7606365)
1. Mapping of gene loci in the Q13-Q15 region of chromosome 12. Mitchell EL; White GR; Santibanez-Koref MF; Varley JM; Heighway J Chromosome Res; 1995 Jun; 3(4):261-2. PubMed ID: 7606365 [TBL] [Abstract][Full Text] [Related]
3. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848 [TBL] [Abstract][Full Text] [Related]
4. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701 [TBL] [Abstract][Full Text] [Related]
5. The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. Forus A; Flørenes VA; Maelandsmo GM; Fodstad O; Myklebost O Cancer Genet Cytogenet; 1994 Dec; 78(2):165-71. PubMed ID: 7828148 [TBL] [Abstract][Full Text] [Related]
7. A 6-Mb yeast artificial chromosome contig and long-range physical map encompassing the region on chromosome 12q15 frequently rearranged in a variety of benign solid tumors. Schoenmakers EF; Geurts JM; Kools PF; Mols R; Huysmans C; Bullerdiek J; Van den Berghe H; Van de Ven WJ Genomics; 1995 Oct; 29(3):665-78. PubMed ID: 8575759 [TBL] [Abstract][Full Text] [Related]
8. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854 [TBL] [Abstract][Full Text] [Related]
10. Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland. Rao PH; Murty VV; Louie DC; Chaganti RS Cancer Genet Cytogenet; 1998 Sep; 105(2):160-3. PubMed ID: 9723034 [TBL] [Abstract][Full Text] [Related]
11. The 12q13-q15 translocation breakpoints in pleomorphic adenoma and clear-cell sarcoma of tendons and aponeuroses are different from that in myxoid liposarcoma. Stenman G; Sahlin P; Mark J; Chaganti RS; Kindblom LG; Aman P Genes Chromosomes Cancer; 1993 Jul; 7(3):178-80. PubMed ID: 7687873 [TBL] [Abstract][Full Text] [Related]
12. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Khatib ZA; Matsushime H; Valentine M; Shapiro DN; Sherr CJ; Look AT Cancer Res; 1993 Nov; 53(22):5535-41. PubMed ID: 8221695 [TBL] [Abstract][Full Text] [Related]
13. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Berner JM; Forus A; Elkahloun A; Meltzer PS; Fodstad O; Myklebost O Genes Chromosomes Cancer; 1996 Dec; 17(4):254-9. PubMed ID: 8946207 [TBL] [Abstract][Full Text] [Related]
14. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti MA J Pathol; 1998 Jun; 185(2):188-90. PubMed ID: 9713346 [TBL] [Abstract][Full Text] [Related]
15. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978 [TBL] [Abstract][Full Text] [Related]
16. A long range restriction map spanning the myxoid liposarcoma breakpoint in the q13-14 region of human chromosome 12. Forus A; Kools PF; Schoenmakers EF; Van de Ven WJ; Myklebost O Hum Genet; 1994 Sep; 94(3):259-64. PubMed ID: 8076941 [TBL] [Abstract][Full Text] [Related]
17. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation. Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873 [TBL] [Abstract][Full Text] [Related]
18. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Aman P; Ron D; Mandahl N; Fioretos T; Heim S; Arheden K; Willén H; Rydholm A; Mitelman F Genes Chromosomes Cancer; 1992 Nov; 5(4):278-85. PubMed ID: 1283316 [TBL] [Abstract][Full Text] [Related]
19. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. Ragazzini P; Gamberi G; Benassi MS; Orlando C; Sestini R; Ferrari C; Molendini L; Sollazzo MR; Merli M; Magagnoli G; Bertoni F; Bohling T; Pazzagli M; Picci P Cancer Detect Prev; 1999; 23(2):129-36. PubMed ID: 10101594 [TBL] [Abstract][Full Text] [Related]
20. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Wei G; Lonardo F; Ueda T; Kim T; Huvos AG; Healey JH; Ladanyi M Int J Cancer; 1999 Jan; 80(2):199-204. PubMed ID: 9935200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]